Bentley Pharmaceuticals (BNT) Misses Q1 EPS Views
More News related to BNT
- Notable Mergers and Acquisitions of the Day 7/23 (CSCO, BNT/TEVA, PHLY)
- Bentley (BNT) Shareholders Approve Merger with TEVA Pharma (TEVA)
- Bentley Pharma (BNT) Announces Adjustment To Teva (TEVA) Merger Price
- Bentley Pharmaceuticals (BNT) Misses Q1 EPS Views
- Unusual 11 Mid-Day Movers 3/31: ANST, VRTX, BNT, XJT Higher; SGP, FRP, TMA, MRK Lower
More News related to Earnings
- HNI Corporation (HNI) Tops Q1 EPS by 2c; Revs Light
- Team Health (TMH) Reports Mixed Q4 Results
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
Bentley Pharmaceuticals Inc. (NYSE: BNT) reports Q1 earnings of $0.05 per share, below the consensus of $0.12. Revenues came in at $40 million, versus the consensus of $34.9 million.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
